Fc Fusion Protein Market

Fc fusion protein is composed of the Fc segment of immunoglobulin and protein molecules with biological activity. The Fc segment and the functional protein have relatively independent structural domains and functions, which can affect the physical and chemical properties and biological activities of the fusion protein from different angles.

Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure?function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins

Fc Fusion Protein Market will focus on Fc fusion protein drugs.

Fc Fusion Protein Market contains market size and forecasts of Fc Fusion Protein in global, including the following market information:

Global Fc Fusion Protein Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Fc Fusion Protein Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Fc Fusion Protein companies in 2021 (%)

The global Fc Fusion Protein market was valued at 30320 million in 2021 and is projected to reach US$ 60000 million by 2028, at a CAGR of 10.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Brands Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Fc Fusion Protein include Sanofi, Bristol-Myers Squibb, Regeneron, Bayer, Amgen, Pfizer, Eli Lilly and Company, Sobi and Kanghong Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Fc Fusion Protein manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fc Fusion Protein Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Fc Fusion Protein Market Segment Percentages, by Type, 2021 (%)

• Brands Drugs
• Biosimilar Drugs

Global Fc Fusion Protein Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Fc Fusion Protein Market Segment Percentages, by Application, 2021 (%)

• Autoimmune Disease
• Eye Diseases
• Diabetes
• Hemophilia

Global Fc Fusion Protein Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Fc Fusion Protein Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Fc Fusion Protein revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Fc Fusion Protein revenues share in global market, 2021 (%)
• Key companies Fc Fusion Protein sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Fc Fusion Protein sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Bristol-Myers Squibb
• Regeneron
• Bayer
• Amgen
• Pfizer
• Eli Lilly and Company
• Sobi
• Kanghong Pharma
• 3SBIO
• Celgen Biopharma